Asialoerythropoietin attenuates neuronal cell death in the hippocampal CA1 region after transient forebrain ischemia in a gerbil model

Neurological Research

Volumn 32, Issue 9, 2010, Pages 957-962

  Yamashita, Taro ^a   Nonoguchi, Naosuke ^a   Ikemoto, Toshiyuki ^a   Miyatake, Shin Ichi ^a   Kuroiwa, Toshihiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Apoptosis; Asialoerythropoietin; Brain ischemia; Neuroprotection

Indexed keywords

ASIALOERYTHROPOIETIN; ERYTHROPOIETIN; PHOSPHATE BUFFERED SALINE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CELL VIABILITY; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROPOIESIS; FOREBRAIN; GERBIL; HIPPOCAMPUS; HISTOLOGY; LEARNING; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; TREATMENT OUTCOME;

ANIMALS; ASIALOGLYCOPROTEINS; AVOIDANCE LEARNING; CA1 REGION, HIPPOCAMPAL; CAROTID ARTERY DISEASES; CELL COUNT; CELL DEATH; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; GERBILLINAE; IN SITU NICK-END LABELING; ISCHEMIC ATTACK, TRANSIENT; NEURONS; NEUROPROTECTIVE AGENTS; PROSENCEPHALON;

EID: 77957552870     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164110X12700393823336     Document Type: Article

References (22)

1. Krantz SB. Erythropoietin. Blood. 1991; 77: 419-34.
2. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med. 2003;228:1-14.
3. Tan CC, Eckardt KU, Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol. 1992;263:F474-81.
4. Juul SE, Anderson DK, Li Y, Christensen RD. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res. 1998;43:40-9.
5. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA. 1998;95:4635-40.
6. Juul SE. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr Suppl. 2002;91:36-42.
7. Brines M, Cerami A. Emerging biological roles for erythropoie-tin in the nervous system. Nat Rev Neurosci. 2005;6:484-94.
8. Genc S, Koroglu TF, Genc K. Erythropoietin as a novel neuroprotectant. Restor Neurol Neurosci. 2004;22:105-19.
9. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8:495-505.
10. Ehrenreich H, Aust C, Krampe H, Jahn H, Jacob S, Herrmann M, et al. Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis. 2004;19:195-206.
11. Brines M, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci. 2000;97:10526-31.
12. WolfRF, Peng J, Friese P, Gilmore LS, Burstein SA, Dale GL. Erythropoietin administration increases production and reac-tivity ofplatelets in dogs. Thromb Haemost. 1997;78:1505-9.
13. Imai N, Higuchi M, Kawamura A, Tomonoh K, Oh-Eda M, Fujiwara M, et al. Physicochemical and biological character-ization of asialoerythropoietin: suppressive effects of sialic acid in the expression of biological activity of human erythropoietin in vitro. Eur J Biochem. 1990;194:457-62.
14. Fukuda MN, Sasaki H, Lopez L, Fukuda M. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood. 1989:73:84-9.
15. Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA. 2003;100:6741-6.
16. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982;239:57-69.
17. O'Neil MJ. Clemens JA. Rodent models of global cerebral ischemia. Curr Protoc Neurosci. 2000;Chapter 9:unit 9.5.
18. Nanri M, Yamamoto J, Miyake H, Watanabe H. Protective effect of GTS-21, a novel nicotinic receptor against, on delayed neuronal death induced by ischemia in gerbils. Jpn J Phrmacol. 1998;76:23-9.
19. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76:105-16.
20. Wang X, Zhu C, Wang X, Gerwien JG, Schrattenholz A, Sandberg M, et al. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem. 2004;91:900-10.
21. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004;305:239-42.
22. Wen TC, Sadamoto Y, Tanaka J, Zhu PX, Nakata K, Ma YJ, et al. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expres-sion. J Neurosci Res. 2002;67:795-803.